How drug­mak­ers are han­dling new pres­sure to re­cy­cle plas­tic in­jec­tion pens as mil­lions of new pa­tients be­gin us­ing GLP-1s

On plas­tic chairs made from dis­card­ed obe­si­ty and di­a­betes drug pen in­jec­tors, No­vo Nordisk is lit­er­al­ly sit­ting on its block­buster GLP-1 so­lu­tion. The cafe­te­ria in its newest site in Den­mark is full of chairs and oth­er fur­ni­ture made from dis­card­ed and re­cy­cled di­a­betes and obe­si­ty sin­gle-use pens.

As mil­lions of pre­scrip­tions get writ­ten, lead­ing to even more mil­lions of dis­card­ed pens, the av­er­age per­son may al­so some­day sit on a chair made from the up­cy­cled byprod­ucts of a trend­ing obe­si­ty treat­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER